Summary

The Senior Financial Analyst role will be responsible for supporting the US Distribution Network and Global Logistic Partners. This role will be key in supporting sustainable improvements across our financial processes and capabilities to scale for future growth. Responsibilities include month-end close activities, standard costing, sox control testing, financial and strategic planning, and reporting. This position requires an outgoing candidate that can work independently, while building strong business partnerships with a goal to optimize financial process flows, planning, reporting and analysis, utilizing appropriate financial concepts and techniques.

Job description

About the role

The Senior Financial Analyst role will be responsible for supporting the US Distribution Network and Global Logistic Partners. This role will be key in supporting sustainable improvements across our financial processes and capabilities to scale for future growth. Responsibilities include month-end close activities, standard costing, sox control testing, financial and strategic planning, and reporting. This position requires an outgoing candidate that can work independently, while building strong business partnerships with a goal to optimize financial process flows, planning, reporting and analysis, utilizing appropriate financial concepts and techniques.

Key responsibilities include:

Partner independently with the site functional managers and corporate business partners
Support of standard cost creation and analysis within SAP
Prepare and distribute financial reporting packages by gathering and analyzing information related to current performance
Perform financial analysis and recommend courses of action by utilizing appropriate financial tools, policy adherence and creative problem solving
Prepare journal entries and assist in month end close as needed to ensure proper accounting at the functional and departmental level
Maintain robust controls environment with function

Requirements

Bachelor's degree in Finance, Accounting, Business, or a related field
3+ years of progressive, end-to-end financial analysis and/or accounting experience
Demonstrated knowledge and application of accounting principles and financial analysis techniques
Knowledge and experience with US GAAP, internal controls, and their impact on end-to-end processes, financial statements, and financial statement assertions
Strong problem-solving skills, including the ability to diagnose issues related to processes, technology, strategy, or people and implement effective solutions
Strong communication, collaboration, and interpersonal skills, with the ability to influence stakeholders at all levels
Strong financial acumen, including the ability to develop business cases and compelling value propositions for process improvement initiatives
5+ years of progressive, end-to-end financial analysis and/or accounting experience (preferred)
MBA, CPA, or other relevant advanced degree or professional certification is a plus (preferred)
Experience with business process improvement methodologies (preferred)
Experience with ERP systems, particularly SAP S/4 (preferred)
Experience with business intelligence and analytics platforms (Hyperion preferred)
Demonstrated ability to implement successful issue resolution measures and effectively communicate solutions to stakeholders (preferred)
Strong consulting and team-building skills (preferred)

Benefits

Annual bonus target
Long-term incentives

Company overview

Boston Scientific Corporation is a global leader in the development, manufacturing, and marketing of minimally invasive medical devices used in interventional medical specialties. Founded in 1979 and headquartered in Marlborough, Massachusetts, the company focuses on transforming patient lives through innovative medical solutions across a wide range of therapeutic areas including cardiology, endoscopy, urology, pulmonology, and neuromodulation. With approximately 53,000 employees worldwide and operations in 40 countries, Boston Scientific serves over 44 million patients annually. The company invests heavily in research and development, allocating $1.6 billion to R&D in 2024, and maintains a strong commitment to quality, patient safety, and meaningful innovation. Boston Scientific's product portfolio includes advanced technologies such as cardiac rhythm management devices, coronary stents, ablation systems, endoscopy equipment, and neuromodulation therapies, all designed to improve patient outcomes and quality of life through less invasive treatment options.